Skip to content

Home
Team
Portfolio
News
- TCG News
- Portfolio News
Careers
Contact

Menu

Home
Team
Portfolio
News
- TCG News
- Portfolio News
Careers
Contact

Month: December 2018

Gritstone Oncology Announces FDA Fast Track Designation for GRANITE-001 for the Treatment of Colorectal Cancer

Portfolio News / By admin

December 20, 2018

Carmot Therapeutics Initiates Phase 1 Trial to Treat Type 2 Diabetes

Portfolio News / By admin

December 19, 2018

Gritstone Oncology Announces Publication in Nature Biotechnology of Neoantigen Identification Capabilities of its Artificial Intelligence Platform, EDGE™

Portfolio News / By admin

December 17, 2018

Gritstone Oncology Advances Solid Tumor Bispecific Antibody Program into Lead Optimization Phase; Appoints Vice President of Antibody Therapeutics to Spearhead

Portfolio News / By admin

December 10, 2018

Constellation Pharmaceuticals Initiates Phase 2 Portion of ProSTAR Clinical Trial in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Portfolio News / By admin

December 10, 2018

Kallyope Inc. Announces $21 Million Expansion of Series B Financing

Portfolio News / By admin

December 5, 2018

Search for:

Recent Posts

Atavistik Bio Announces $60 Million Series A Financing to Advance Genetically-Validated Targets in Metabolic Diseases and Cancer
NGM Bio Discloses Fourth Oncology Development Candidate, NGM831, an ILT3 Antagonist Antibody, Coinciding with Publication in Cancer Immunology Research
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
RAPT Therapeutics Reports Second Quarter 2021 Financial Results
Revolution Medicines Reports Second Quarter Financial Results and Update on Corporate Progress

Recent Comments

Archives

Categories

Portfolio News
TCG News

The Column Group

Copyright © 2021. The Column Group | Privacy Policy | Terms of Use
Website developed by CP Communications

Scroll to Top